Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    DTRA Seeks Next Generation Sequencing for Biothreat Agents

    By Global Biodefense StaffOctober 1, 2012
    Share
    Facebook LinkedIn Reddit Email

    The Defense Threat Reduction Agency (DTRA) has issued a Request for Information to identify sources with the capability to amplify, sequence, and assemble sequence data for biothreat agents into high-quality genomes.

    The Next Generation Sequencing (NGS) effort is specifically looking to identify sources that can perform these pathogen characterization tasks for a large volume of samples on a yearly basis, with little or no government investment in instruments or infrastructure.

    Rapidly and efficient characterization of biothreat agents genomes generates invaluable data which can be utilized to design molecular assays and diagnostics.

    Information gathered in response to this RFI will be used to support the development of a strategic plan for notional future DTRA investments in genomics and NGS.  It is envisioned that the genomics portfolio at DTRA will be able to fund the sequencing on the order of hundreds or thousands of pathogens per year.

    Respondents should be able to demonstrate the ability to culture and propagate select agents and toxins including the appropriate permits to receive live select agents and the required Biosafety Level (BSL) 4 facilities for certain agents. Respondents should also have the demonstrated ability to assemble bacterial genomes into “finish” status including species with high or low GC content, large repeat regions, and other genomic structures which can impede genome assembly.

    This RFI is targeted to mature organizations and institutions that have demonstrated the ability to comprehensively perform end-to-end NGS in such environments. Sources with development efforts focused on decreasing the cycle time are encouraged to outline their research and development efforts.

    The RFI was issued by the Diagnostics, Detection and Disease Surveillance Division, Chemical and Biological Technologies Department at DTRA. The responses from companies will be used to inform a strategic plan for notional future DTRA investments in genomics and NGS.

    Further details are available under Solicitation Number: HDTRA1-12-CBA-0005. The response deadline is October 31, 2012.

    Biosafety Chemical Detection Defense Threat Reduction Agency RFI
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleMRIGlobal Awarded $17.9M Pentagon CBRN Contract
    Next Article Hertfordshire Receives BARDA Award for Mass Casualty Decon Studies

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy